Compare BridgeBio Pharma Inc (BBIO) vs Mondaycom Ltd (MNDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Mondaycom Ltd — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.61B), while Mondaycom Ltd trades at $86.77 (market cap $3.76B). The key difference: BridgeBio Pharma Inc is far larger — about 4.4× Mondaycom Ltd's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Mondaycom Ltd nearer its low. Which is the better fit depends on your goals.
| BBIO | MNDY | |
|---|---|---|
Market Cap | $16.61B | $3.76B |
Sector | Health | Technology |
52-Week High | $90.17 | $219.15 |
52-Week Low | $47.29 | $58.81 |
Enterprise Value | $18.16B | $2.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Monday.com (MNDY) trades at $93.13, up 6.35% with strong technical momentum and bullish moving average signals. The company delivered another earnings beat with Q2 2026 EPS of $1.48 versus $1.14 expected, though recent news highlights investor concerns over Q3 revenue guidance. Fundamentals show robust 89% gross margins and consistent profitability, while valuation ratios remain elevated with a P/E of 38.85.
The outlook remains positive with 76% analyst buy ratings and a $120 consensus target, representing 29% upside potential. Key risks include slower revenue growth guidance and competitive pressures in the SaaS sector. The stock's recent volatility reflects the tension between strong current performance and forward-looking concerns about growth sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Mondaycom Ltd
Monday.com Ltd. is a cloud-based software company providing a Work OS (Operating System) that enables organizations to manage projects, processes, and daily work. The platform is highly customizable, enabling teams to build tailored applications and workflows for a range of use cases, from marketing and sales to software development and HR. monday.com serves clients across numerous industries, aiming to improve transparency, collaboration, and efficiency across the entire enterprise.
Read more on MNDY →
